UPDATE: Roche Touts New, Upcoming Launches as Dx Revenues Drop 31 Percent
The company's point-of-care revenues dropped 73 percent, while molecular lab sales declined 50 percent.
Source: 360dx.com
Stay updated with breaking news from Benchmark Ultra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company's point-of-care revenues dropped 73 percent, while molecular lab sales declined 50 percent.